共 166 条
[1]
Alboni P(2004)Outpatient treatment of recent-onset atrial fibrillation with the "pill-in-the-pocket" approach N Engl J Med 351 2384-2391
[2]
Botto GL(2004)Bioequivalence revisited: influence of age and sex on CYP enzymes Clin Pharmacol Ther 76 618-627
[3]
Baldi N(1982)Relationship between plasma concentrations and suppression of ventricular extrasystoles by flecainide acetate (R-818), a new antiarrhythmic, in patients Arzneimittelforschung 32 155-159
[4]
Luzi M(1984)Metabolism of flecainide Am J Cardiol 53 41B-51B
[5]
Russo V(1987)Flecainide acetate for conversion of acute supraventricular tachycardia to sinus rhythm Am J Cardiol 59 607-609
[6]
Gianfranchi L(2004)Absorption kinetics and pharmacodynamics of two oral dosage forms of flecainide in patients with an episode of paroxysmal atrial fibrillation Eur J Clin Pharmacol 60 693-701
[7]
Marchi P(2004)Simultaneous determination of serum flecainide and its metabolites by using high performance liquid chromatography J Pharm Biomed Anal 35 1307-1312
[8]
Calzolari M(1988)Flecainide pharmacokinetics after multiple dosing in patients with impaired renal function J Clin Pharmacol 28 727-735
[9]
Solano A(2000)The decreased in vivo clearance of CYP2D6 substrates by CYP2D6*10 might be caused not only by the low-expression but also by low affinity of CYP2D6 Arch Biochem Biophys 380 303-308
[10]
Baroffio R(1994)Variable disposition kinetics and electrocardiographic effects of flecainide during repeated dosing in humans: contribution of genetic factors, dose-dependent clearance, and interaction with amiodarone Clin Pharmacol Ther 55 256-269